Frontiers in MedicinePub Date : 2026-10-30eCollection Date: 2026-01-01DOI: 10.3389/fmed.2026.1960861
Jiangbo Li, Bojun Li, Xiang Pei, Bo Li, Dandan Du, Li Zhang
{"title":"Analysis of pathogen distribution, clinical features and factors associated with lower respiratory tract multidrug-resistant organism isolation in patients with infectious pneumonia.","authors":"Jiangbo Li, Bojun Li, Xiang Pei, Bo Li, Dandan Du, Li Zhang","doi":"10.3389/fmed.2026.1960861","DOIUrl":"https://doi.org/10.3389/fmed.2026.1960861","url":null,"abstract":"<p><strong>Objective: </strong>To investigate pathogen distribution, clinical characteristics, and factors associated with lower respiratory tract multidrug-resistant organism (MDRO) isolation in patients with infectious pneumonia, and to develop an exploratory prediction-oriented nomogram.</p><p><strong>Methods: </strong>We retrospectively analyzed 117 patients with infectious pneumonia at Tianjin Chest Hospital from September 2024 to September 2025. Bacterial culture was positive in 102 patients. Patients were divided into an MDRO group (<i>n</i> = 38) and a non-MDRO group (<i>n</i> = 79; 64 with non-MDRO isolates and 15 culture-negative). Pathogen culture, identification, and susceptibility testing were performed. Clinical features were compared, and univariate and binary logistic regression identified factors associated with MDRO isolation. A prediction-oriented nomogram excluding length of RICU stay was developed and internally validated using ROC and calibration curves and 1000 bootstrap resamples.</p><p><strong>Results: </strong>MDRO isolation occurred in 38 patients: 37.25% (38/102) of culture-positive and 32.48% (38/117) of all enrolled patients. After deduplication, 81 MDRO isolates were identified; 75.31% were Gram-negative and 24.69% Gram-positive. The most common MDROs were Klebsiella pneumoniae (57.89%), Pseudomonas aeruginosa (42.11%), and Acinetobacter baumannii (34.21%); Gram-positive MDROs occurred in 9 patients (23.68%), mostly Staphylococcus aureus (21.05%). The MDRO group had longer RICU stays, higher rates of diabetes, hypoproteinemia, invasive mechanical ventilation, and combined antimicrobial therapy, and lower Glasgow Coma Scale (GCS) scores (all <i>P</i> < 0.05). Binary logistic regression identified diabetes (adjusted odds ratio [aOR] = 2.119), invasive mechanical ventilation (aOR=2.849), combined antimicrobial therapy (aOR=2.492), and prolonged RICU stay (aOR=1.137) as associated with MDRO isolation; higher GCS score (aOR=0.674) was associated with lower odds (all <i>P</i> < 0.05). The nomogram showed an apparent AUC of 0.862 (95% CI: 0.793-0.931), sensitivity 82.4%, specificity 87.8%, and an optimism-corrected AUC of 0.831 after 1000 bootstrap resamples. Calibration was acceptable (Brier score=0.142, intercept=-0.02, slope=0.88), with some underestimation at intermediate and overestimation at higher predicted probabilities.</p><p><strong>Conclusion: </strong>MDRO isolation is common in infectious pneumonia, predominantly Gram-negative bacteria. Diabetes, invasive mechanical ventilation, combined antimicrobial therapy, and prolonged RICU stay were associated with MDRO isolation, while higher GCS score was associated with lower odds. An exploratory prediction-oriented nomogram incorporating these factors was constructed but requires prospective validation.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1960861"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759282/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in MedicinePub Date : 2026-10-30eCollection Date: 2026-01-01DOI: 10.3389/fmed.2026.1962270
Jie Chen, Zhewen Luo, Ping Hua, Biying Wang, Xing Wang
{"title":"Central nervous system involvement in relapsing polychondritis with inflammatory changes in the cerebrospinal fluid and cranial MRI abnormalities: a case series report.","authors":"Jie Chen, Zhewen Luo, Ping Hua, Biying Wang, Xing Wang","doi":"10.3389/fmed.2026.1962270","DOIUrl":"https://doi.org/10.3389/fmed.2026.1962270","url":null,"abstract":"<p><strong>Objective: </strong>To explore the clinical features of relapsing polychondritis (RP) with central nervous system (CNS) involvement as the major manifestation.</p><p><strong>Methods: </strong>A total of 11 RP patients who were hospitalized in the Department of Neurology, the Affiliated Brain Hospital of Nanjing Medical University from January 2020 to December 2024 were retrospectively enrolled. Their clinical manifestations, laboratory indicators, cerebrospinal fluid (CSF) changes, and cranial magnetic resonance imaging (MRI) findings were comprehensively analyzed.</p><p><strong>Results: </strong>CNS involvement was the major initial manifestation in the vast majority of RP patients (90.9%, 10/11), as cognitive impairment (<i>n</i> = 10), headache (<i>n</i> = 7), psychiatric/behavioral symptoms (<i>n</i> = 6), epileptic seizures (<i>n</i> = 4), limb numbness (<i>n</i> = 4), limb weakness (<i>n</i> = 4), and limb tremor (<i>n</i> = 3). CSF analysis revealed an inflammatory response in the CNS, as evidenced by increased levels of neutrophils, albumin, and immunoglobulins at varying degrees. White matter degeneration (<i>n</i> = 7) and brain atrophy (<i>n</i> = 7) were the pronounced changes on cranial MRI. Brain lesions were mainly distributed in the cortex, subcortex, and infratentorium. Parenchymal or meningeal enhancement was observed on MRI scans in three RP patients with CNS involvement. Arterial spin labeling (ASL) detected three cases of hypoperfusion and two cases of hyperperfusion in the brain. All patients were treated with corticosteroids, and six were managed with additional immunotherapies. Finally, ten RP patients were improved and discharged.</p><p><strong>Conclusion: </strong>neurological deficits vary widely in RP patients with CNS involvement, with cognitive decline as the most common feature. Inflammatory changes in the CSF indicate a neuroinflammatory mechanism involved in the pathogenesis of RP. Distinct imaging features on cranial MRI are closely associated with the involvement into CNS in RP, offering references for distinguishing the acute inflammation stage from the chronic degeneration stage during the development of RP.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1962270"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404308","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in MedicinePub Date : 2026-10-30eCollection Date: 2026-01-01DOI: 10.3389/fmed.2026.1913119
Xiaoshan Du, Yinglin Wu, Shengkui Wang, Gang Ni
{"title":"Development of a mortality prognostic model based on the Pneumonia Severity Index for older adults with pneumonia in integrated medical and older adult care institutions: a retrospective study.","authors":"Xiaoshan Du, Yinglin Wu, Shengkui Wang, Gang Ni","doi":"10.3389/fmed.2026.1913119","DOIUrl":"https://doi.org/10.3389/fmed.2026.1913119","url":null,"abstract":"<p><strong>Background: </strong>Population aging has increased the demand for integrated medical and long-term care services, particularly in China. Age-related respiratory impairment and immunosenescence render institutionalized older adults at a high risk for pneumonia-associated with poorer outcomes than community-acquired pneumonia. We aimed to investigate the prognostic value of the Pneumonia Severity Index (PSI) for mortality in older adults with pneumonia in integrated medical and elderly care facilities, and to develop a prognostic prediction model.</p><p><strong>Methods: </strong>Medical records of older adult patients with pneumonia admitted to the integrated medical-elderly care ward of the Department of Geriatrics, Hefei First People's Hospital from June 2019 to June 2024 were retrospectively retrieved. A total of 312 patients were enrolled according to predefined inclusion and exclusion criteria. Patients were divided into a survival group (<i>n</i> = 232) and a non-survival group (<i>n</i> = 80) based on post-treatment clinical outcomes. Univariate analyses were performed to compare clinical characteristics between the two groups. All clinical variables were screened using Least Absolute Shrinkage and Selection Operator (LASSO) regression. Variables with non-zero coefficients were subsequently incorporated into Firth's bias-corrected logistic regression to construct the prediction model, followed by model validation.</p><p><strong>Results: </strong>Univariate analysis revealed significant intergroup differences in age ≥80 years, coronary heart disease, white blood cell count (WBC),neutrophil count, multidrug-resistant organism (MDRO) infection, PSI score, hemoglobin, creatinine, coronavirus disease 2019 (COVID-19)infection, Clinical Frailty Scale (CFS) score >7, Prognostic Nutritional Index (PNI) < 35, and C-reactive protein (CRP) (all <i>P</i> ≤ 0.05). LASSO regression with <i>λ</i> = 0.0678392 identified six non-zero predictor variables: White blood cell count, MDRO infection, PSI score, CFS score >7, PNI <35, and CRP. A nomogram was developed using the coefficients obtained from Firth's bias-corrected logistic regression. The ROC analysis yielded an AUC of 0.889, sensitivity of 80%, specificity of 89%,and optimal cutoff value of 0.719. The model exhibited significantly better discriminative performance than PSI alone. Internal validation with 1000 bootstrap resamples produced a corrected AUC of 0.878, calibration slope of 0.9316, and intercept of -0.0584. Decision curve analysis (DCA) showed substantial net benefit within the threshold probability range of 0-0.6. The calibration curve demonstrated good agreement between predicted and observed mortality risks of the nomogram.</p><p><strong>Conclusion: </strong>PSI is an independent risk factor for mortality among older adults with pneumonia in integrated medical and elderly care facilities. The model combining PSI with white blood cell count, MDRO infection, CFS score >7, PNI <35,","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1913119"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759427/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in MedicinePub Date : 2026-10-30eCollection Date: 2026-01-01DOI: 10.3389/fmed.2026.1935253
Ruoqing Li, Lijun Qu, Shiyang Niu
{"title":"Hypopyon from observation to insight: a multidimensional system involving pathogenesis, lesion nature, clinical manifestations and diagnosis and treatment.","authors":"Ruoqing Li, Lijun Qu, Shiyang Niu","doi":"10.3389/fmed.2026.1935253","DOIUrl":"https://doi.org/10.3389/fmed.2026.1935253","url":null,"abstract":"<p><p>Hypopyon is a pivotal clinical sign guiding diagnosis, treatment selection and efficacy evaluation in ophthalmology. However, its overlapping etiologies, atypical presentations of rare emerging pathogens, and the lack of rapid differential tools between infectious and sterile inflammation frequently lead to delayed diagnosis, inappropriate management and irreversible visual impairment. Recent advances in multiplex molecular pathogen detection, quantitative AS-OCT imaging, and mNGS offer new perspectives for investigating the etiology of hypopyon. However, evidence that these modalities refine multi-dimensional phenotypic stratification remains limited, and challenges including variable diagnostic accuracy and the absence of standardized interpretation protocols persist. This review summarizes the pathogenesis, clinical features and classification framework of hypopyon, covering infectious/non-infectious origins, primary/secondary occurrence, and true hypopyon/pseudohypopyon. It provides an up-to-date, evidence-based reference for accurate differential diagnosis and individualized clinical management.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1935253"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in MedicinePub Date : 2026-10-30eCollection Date: 2026-01-01DOI: 10.3389/fmed.2026.1977161
Xiaolong Li, Shuhao Xu, Yinhe Feng, Rongli Wang, Xin Wang
{"title":"A fatal threat: <i>Pneumocystis jirovecii</i> pneumonia with rapidly progressive interstitial lung disease in anti-MDA5-positive dermatomyositis-a case report.","authors":"Xiaolong Li, Shuhao Xu, Yinhe Feng, Rongli Wang, Xin Wang","doi":"10.3389/fmed.2026.1977161","DOIUrl":"https://doi.org/10.3389/fmed.2026.1977161","url":null,"abstract":"<p><p><i>Pneumocystis jirovecii pneumonia</i> (PJP) is a respiratory infection caused by <i>Pneumocystis</i> organisms, representing an opportunistic fungal infection. The clinical occurrence of PJP combined with rapidly progressive interstitial lung disease (RP-ILD) in dermatomyositis (DM) have also been reported occasionally, but patients with this combination of conditions experience rapid disease progression and high mortality rates. We reported a 70-year-old female patient with dyspnea and fever, detailing her laboratory tests, computed tomography (CT) findings and bronchoalveolar lavage fluid findings. The patient's main clinical manifestations were dyspnea and fever. CT scans revealed scattered reticular opacities and ground-glass opacities in both lungs and metagenomic next-generation sequencing (mNGS) of the bronchoalveolar lavage fluid detected <i>Pneumocystis</i> jirovecii. Laboratory tests revealed positive anti-MDA5 antibodies during hospitalization. The patient was treated with high-flow oxygen therapy and methylprednisolone upon admission. Subsequently, the patient received mechanical ventilator support and was administered trimethoprim-sulfamethoxazole (TMP-SMX), plasma exchanges and immunoglobulin treatment. The patient's fever subsided, but respiratory failure and interstitial lung disease continued to progressively worsen. Ground-glass opacities, mixed ground-glass opacities, consolidations and reticular opacities were significantly more pronounced than on admission, indicating RP-ILD changes post-treatment. The patient succumbed after 13 days of treatment. PJP complicated by rapidly progressive interstitial lung disease can be fatal in patients, emphasizing the critical importance of early identification of PJP and prompt initiation of anti-PJP treatment. It is crucial to recognize that some MDA5+ DM patients may not present with the typical rash, and in certain cases, RP-ILD may be the primary manifestation. Therefore, early screening for anti-MDA5 antibodies is essential for patients presenting with unexplained early-stage RP-ILD.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1977161"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759720/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404244","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Cutaneous reporting patterns of drugs relevant to hepatocellular carcinoma: a cross-indication FAERS analysis and proposed management framework.","authors":"Xiubo Sun, Zhe Liu, Jing Zhang, Lijie Zhai, Ling Yu","doi":"10.3389/fmed.2026.1959163","DOIUrl":"https://doi.org/10.3389/fmed.2026.1959163","url":null,"abstract":"<p><strong>Background: </strong>First-line therapy for unresectable hepatocellular carcinoma (HCC) includes combinations of an immune checkpoint inhibitor (ICI) with an anti-angiogenic agent or tyrosine kinase inhibitor. Cutaneous adverse events are frequent, but immune-mediated eruptions and drug-induced reactions such as hand-foot skin reaction are routinely counted together, distorting the apparent skin toxicity signal and risking inappropriate interruption of the checkpoint inhibitor.</p><p><strong>Methods: </strong>In a disproportionality analysis using cross-indication reports from the US FDA Adverse Event Reporting System via openFDA, we computed reporting odds ratios (RORs; signal: ≥3 reports and lower 95% confidence limit >1) for 16 cutaneous reaction search phrases across 9 ICIs and 5 anti-angiogenic/multikinase agents relevant to HCC or used as class comparators. Proportional reporting ratios and information components were sensitivity measures. We examined co-reporting within selected combinations; reports were not restricted to HCC. An independent quarterly data sensitivity analysis compared primary-suspect, primary/secondary-suspect, and any-role coding with and without case version consolidation.</p><p><strong>Results: </strong>In the original analysis, vitiligo (ROR up to 40.95 for ipilimumab) and lichen planus generated signals for the six more extensively represented ICIs but not for the five anti-angiogenic/multikinase agents. Hand-foot skin reaction signals emerged for all five anti-angiogenic/multikinase agents (ROR up to 135.40); durvalumab and tremelimumab did not generate ROR signals. Severe reactions (Stevens-Johnson syndrome, toxic epidermal necrolysis) generated signals for several ICIs and some multikinase agents. Of 91 ROR signals, 68 also met both sensitivity criteria. Hand-foot RORs decreased after excluding reports containing selected co-reported medicines (atezolizumab: from 4.19 to 1.82 after excluding bevacizumab-containing reports), suggesting possible confounding by concomitant therapy without establishing drug causality. Camrelizumab and sintilimab had zero reports in the original generic-name query output, and tislelizumab had limited coverage. Quarterly primary-suspect analyses retained all five anti-angiogenic/multikinase hand-foot signals, with agent/event-specific exceptions among ICIs.</p><p><strong>Conclusions: </strong>These cross-indication reporting patterns focus attention on concomitant medicines but do not establish HCC-specific risks or individual drug causality. A proposed multidisciplinary monitoring framework with pharmacist involvement combines these observations with external clinical evidence on reactive cutaneous capillary endothelial proliferation, systemic organ assessment, and severe reactions. The framework and monitoring schedule have not been prospectively validated.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1959163"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759389/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in MedicinePub Date : 2026-10-30eCollection Date: 2026-01-01DOI: 10.3389/fmed.2026.2007153
Shuai Yu, Ruirui Huang, Wenli Zhou, Ning Duan, Wenjie Huang
{"title":"Safety, accuracy, empathy and information quality of six large language models answering patient-facing questions about diabetic kidney disease: a cross-sectional comparative study.","authors":"Shuai Yu, Ruirui Huang, Wenli Zhou, Ning Duan, Wenjie Huang","doi":"10.3389/fmed.2026.2007153","DOIUrl":"https://doi.org/10.3389/fmed.2026.2007153","url":null,"abstract":"<p><strong>Background: </strong>Large language models (LLMs) may support patient education, but their suitability for diabetic kidney disease (DKD) remains uncertain. We compared six publicly accessible LLM chatbots-ChatGPT, Gemini, DeepSeek, Doubao, Kimi, and Qwen-across safety, accuracy, empathy, information quality, and readability, with safety as the primary outcome.</p><p><strong>Methods: </strong>In this CHART-guided cross-sectional study, 42 standardized English DKD questions were submitted once to each chatbot in independent single-turn sessions, generating 252 responses. Five source-masked clinical raters assessed safety, accuracy, empathy, DISCERN, EQIP, JAMA benchmarks, and the Global Quality Scale; readability was assessed automatically. Agreement was evaluated using Fleiss'<i>κ</i> and ICC (2,1)/ICC (2,5). Model differences were tested using Cochran's <i>Q</i> or Friedman tests with Kendall's <i>W</i> and Benjamini-Hochberg correction. Potentially unsafe responses underwent qualitative review.</p><p><strong>Results: </strong>Safety showed substantial agreement (<i>κ</i> = 0.854); ICC (2,1) ranged from 0.552 to 0.855 and ICC (2,5) from 0.860 to 0.967. Safe-response rates ranged from 83.3% to 92.9% without significant between-model differences (<i>P</i> = 0.726). Accuracy and empathy differed significantly (both <i>P</i> < 0.001), with ChatGPT highest for accuracy and Gemini highest for clinician-rated empathy. Information quality also differed significantly, with ChatGPT performing best overall and Doubao lowest. All six readability indices differed across models (all <i>P</i> < 0.001; Kendall's <i>W</i> = 0.139-0.255). DeepSeek had the lowest mean scores on all five grade-level indices and the highest mean FRES, but mean grade-level estimates exceeded the sixth-grade reference level for every model. Thirty of 252 responses (11.9%) were potentially unsafe, most often because of incomplete medication-related information or insufficiently individualized fluid advice.</p><p><strong>Conclusions: </strong>Publicly accessible LLMs can provide plausible DKD information but show variable performance and safety risks. They may support, but should not replace, professional patient education; guideline anchoring, source verification, improved readability, and clinical oversight remain essential.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"2007153"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13759355/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in MedicinePub Date : 2026-10-30eCollection Date: 2026-01-01DOI: 10.3389/fmed.2026.1967105
Lianggang Wei, Jianping Gan, Chunhui Cao, Jing Wang, Yi Ren, Shasha Wang, Min Zhou
{"title":"From metabolic reprogramming to immune homeostasis: the bidirectional regulatory network of HIF-1<i>α</i>/HK2 and Th17/Treg in gout.","authors":"Lianggang Wei, Jianping Gan, Chunhui Cao, Jing Wang, Yi Ren, Shasha Wang, Min Zhou","doi":"10.3389/fmed.2026.1967105","DOIUrl":"https://doi.org/10.3389/fmed.2026.1967105","url":null,"abstract":"<p><p>Gout is a metabolic inflammatory disease whose pathogenesis involves the complex interaction between metabolic reprogramming and immune homeostasis imbalance. This review focuses on the bidirectional network through which the HIF-1<i>α</i>/HK2 axis regulates the Th17/Treg balance via glycolytic reprogramming. Monosodium urate (MSU) crystals drive enhanced aerobic glycolysis in macrophages through the GLUT1-JNK-HIF-1<i>α</i> signaling axis, where hexokinase 2 (HK2), as a metabolic checkpoint, connects glycolysis with NLRP3 inflammasome activation and neutrophil extracellular trap (NETosis)-induced M1 polarization. The glycolytic metabolic bias promotes the differentiation of T helper 17 (Th17) cells while inhibiting the generation of regulatory T (Treg) cells. In turn, cytokines derived from Th17/Treg cells reversely regulate the metabolic status of antigen-presenting cells, forming a feedback loop for inflammation amplification or resolution. Based on this network model, intervention strategies targeting the HIF-1<i>α</i>/HK2/mTOR glycolytic axis and metabolic checkpoints (such as HK2, PKM2), including chaetocin, rapamycin, and various natural products, have shown therapeutic potential for restoring immune homeostasis. Current evidence mainly comes from animal models and <i>in vitro</i> experiments. In the future, it is necessary to use single-cell multi-omics technology to resolve the heterogeneity of the immunometabolic landscape, and to verify the dynamic regulatory mechanism of this network in the self-limiting resolution of gout inflammation.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1967105"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404340","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Ageing and anaesthetic sensitivity: the role of inflammaging in the vulnerable surgical brain.","authors":"Catalina Díaz-Papapietro, Darío Ríos, Rodrigo Brisso, Rodrigo Gutiérrez, José Ignacio Egaña, Antonello Penna","doi":"10.3389/fmed.2026.1920909","DOIUrl":"https://doi.org/10.3389/fmed.2026.1920909","url":null,"abstract":"<p><p>Ageing surgical patients demonstrate increased vulnerability to anaesthetic agents, including heightened sensitivity, reduced drug requirements, and delayed emergence, and they are also at increased risk of postoperative complications such as delirium and haemodynamic instability. These phenomena are only partially understood and have traditionally been attributed to the global functional decline associated with ageing. However, emerging preclinical and clinical evidence suggests that inflammaging and related neuroimmune alterations, including peripheral macrophage activation, blood-brain barrier dysfunction, and immune-to-brain signalling, may also modulate anaesthetic response. This narrative review examines current evidence on anaesthetic sensitivity in older adults, the role of macrophage phenotypes in ageing, and the mechanisms by which neuroinflammation may alter neuronal excitability, synaptic function, and electroencephalographic markers of anaesthetic depth. It also reviews methodological approaches ranging from rodent models to biomarkers such as the cerebrospinal fluid to plasma albumin ratio and EEG-derived indices. Overall, the available literature supports a biologically plausible link between age-related immune dysregulation and altered anaesthetic sensitivity, while also suggesting that these same pathways may contribute to broader perioperative brain vulnerability, including postoperative delirium. Direct clinical evidence remains limited, however, and many mechanistic links continue to rely on extrapolation from preclinical models. Further integrative perioperative studies combining immunological profiling, neurophysiological monitoring, and pharmacodynamic modelling are needed to clarify how neuroimmune ageing influences anaesthetic brain sensitivity in older adults.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1920909"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760567/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Frontiers in MedicinePub Date : 2026-10-30eCollection Date: 2026-01-01DOI: 10.3389/fmed.2026.1938709
Jan Trøst Jørgensen
{"title":"Companion diagnostics and clinical drug development in oncology: a survey based on US FDA data.","authors":"Jan Trøst Jørgensen","doi":"10.3389/fmed.2026.1938709","DOIUrl":"https://doi.org/10.3389/fmed.2026.1938709","url":null,"abstract":"<p><p>Over the past few decades, the drug-diagnostic codevelopment model has gradually transformed oncology drug development. In this model, a predictive biomarker assay, known as a companion diagnostic (CDx), is developed alongside the drug. The incorporation of CDx assays in clinical drug development has facilitated the use of the enrichment trial design, in which patients are selected based on molecular characteristics linked to the drug mechanism of action. In this survey, oncology drugs associated with a CDx assay approved by the FDA until the end of 2025 were investigated, and drug class, clinical trial design, study endpoint, patient population, Orphan Drug status, and expedited review were recorded. During this period, 87 cancer drugs were identified, of which 62 (71%) were indicated for treatment of solid tumors. Kinase inhibitors were the dominant drug class, accounting for 34 drugs (55%). A large proportion of the drugs had obtained Orphan Drug status (63%) and Breakthrough Therapy designation (77%). The average patient population sufficient to obtain FDA approval was 279, with 16 (26%) drugs approved based on fewer than 100 patients, often supported by single-arm, open-label clinical trials. For 49 (79%) of the drugs, efficacy documentation was generated based on one single clinical trial. The primary endpoint in these trials was most often objective response rate and progression-free survival. When evaluating the enrichment trial design, the number of patients required to demonstrate clinical efficacy and obtain FDA approval is low compared to the traditional all-comers design, which means that safety evaluation could be compromised.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1938709"},"PeriodicalIF":3.6,"publicationDate":"2026-10-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13762447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149404311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}